Tiny trial tests daily pill for painful hand and foot skin disease
NCT ID NCT05710185
Summary
This study tested a daily pill called deucravacitinib for adults with a severe, chronic skin condition that causes painful pustules on the palms and soles. The goal was to see if the treatment could reduce skin symptoms by at least 50% and improve patients' quality of life over 24 weeks. The trial was very small and was terminated early, so its results are limited.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PALMOPLANTAR PUSTULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.